{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:38:40Z","timestamp":1780609120977,"version":"3.54.1"},"reference-count":107,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic hepatitis B virus (HBV) infection is a major global health problem with an estimated 400 million HBV carriers worldwide. In the natural history of chronic hepatitis B (CHB), spontaneous acute exacerbation (AE) is not uncommon, with a cumulative incidence of 10%\u201330% every year. While exacerbations can be mild, some patients may develop hepatic decompensation and even die. The underlying pathogenesis is possibly related to the activation of cytotoxic T lymphocyte-mediated immune response against HBV. An upsurge of serum HBV DNA usually precedes the rise of alanine aminotransferase (ALT) and bilirubin. Whether antiviral treatment can benefit CHB with severe AE remains controversial, but early nucleos(t)ide analogues treatment seemed to be associated with an improved outcome. There has been no randomized study that compared the effects of different nucleos(t)ide analogues (NA) in the setting of CHB with severe AE. However, potent NAs with good resistance profiles are recommended. In this review, we summarized current knowledge regarding the natural history, pathogenetic mechanisms, and therapeutic options of CHB with severe AE.<\/jats:p>","DOI":"10.3390\/ijms161226087","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T10:08:53Z","timestamp":1448532533000},"page":"28126-28145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation"],"prefix":"10.3390","volume":"16","author":[{"given":"Wei-Lun","family":"Tsai","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan"},{"name":"School of Medicine, National Yang Ming University, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-6712","authenticated-orcid":false,"given":"Wei-Chi","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan"},{"name":"School of Medicine, National Yang Ming University, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shiung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan"},{"name":"School of Medicine, National Yang Ming University, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B infection","volume":"337","author":"Lee","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0168-8278(90)90069-4","article-title":"Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology","volume":"10","author":"Lok","year":"1990","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2008-1040788","article-title":"Evolving concepts of the clinical and serological consequences of hepatitis B infection","volume":"6","author":"Seeff","year":"1986","journal-title":"Semin. Liver Dis."},{"key":"ref_4","first-page":"521","article-title":"Acute exacerbation and superinfection in patients with chronic viral hepatitis","volume":"94","author":"Liaw","year":"1995","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0016-5085(85)90566-9","article-title":"Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis","volume":"89","author":"Sheen","year":"1985","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-102-6-762","article-title":"Reactivation of chronic type B hepatitis B presenting as acute viral hepatitis","volume":"102","author":"Davis","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jhep.2014.08.033","article-title":"Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management","volume":"61","author":"Chang","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Practice guidelines committee, American Association for the study of liver diseases: Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/gast.2001.22461","article-title":"Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease","volume":"120","author":"Perrillo","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagel","year":"2009","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1172\/JCI115590","article-title":"Acute exacerbations of chronic type B hepatitis are accompamed by increased T cell responses to hepatitis B core and e antigens. Implicabons for hepatitis B e atigen seroconversion","volume":"89","author":"Tsai","year":"1992","journal-title":"J. Chin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.4049\/jimmunol.141.10.3617","article-title":"Comparative immunogeniclty of hepatitis B virus core and E antigens","volume":"141","author":"Milich","year":"1988","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2249.1995.tb03783.x","article-title":"Cytotoxic T cell responses in patients with chronm hepatltrs B virus infection undergoing HBe antigen\/antibody seroconverslon","volume":"102","author":"Waters","year":"1995","journal-title":"Chin. Exp. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1073\/pnas.88.23.10445","article-title":"HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen","volume":"88","author":"Bertolettl","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0168-8278(02)00419-1","article-title":"The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B","volume":"38","author":"Chien","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","article-title":"Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure","volume":"25","author":"Sun","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840050315","article-title":"Natural history of chronic hepatitis B virus infection in Taiwan: Studies of hepatitis B virus DNA in serum","volume":"5","author":"Chu","year":"1985","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis, B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.1840070106","article-title":"Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody positive patients","volume":"7","author":"Liaw","year":"1987","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0676.1990.tb00455.x","article-title":"Acute exacerbation in patients with liver cirrhosis: A clinicopathological study","volume":"10","author":"Liaw","year":"1990","journal-title":"Liver"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/374226","article-title":"Prognostic factors in severe exacerbation of chronic hepatitis B","volume":"36","author":"Yuen","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/00365520701745693","article-title":"Role of genotype and precore\/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation","volume":"43","author":"Tsai","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1572-0241.2002.06065.x","article-title":"Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong","volume":"97","author":"Chan","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1086\/376988","article-title":"Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation","volume":"37","author":"Yuen","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/gut.52.11.1630","article-title":"Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan","volume":"52","author":"Imamura","year":"2003","journal-title":"Gut"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2893.2009.01254.x","article-title":"Hepatitis B virus genotype and basal core promoter\/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis","volume":"17","author":"Ren","year":"2010","journal-title":"J. Viral Hepat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jmv.20024","article-title":"Precore\/corepromoter mutations and genotypes of hepatitis B virus inchronic hepatitis B patients with fulminant or subfulminant hepatitis","volume":"72","author":"Liu","year":"2004","journal-title":"J. Med. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/jhep.2003.50098","article-title":"Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma","volume":"37","author":"Yuen","year":"2003","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJM199106133242404","article-title":"Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis","volume":"324","author":"Omata","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1128\/JCM.43.4.1594-1599.2005","article-title":"Determinants for the occurrence of acute axacerbation of hepatitis B virus infection in Chinese patients after HBeAg sero clearance","volume":"43","author":"Yuan","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1440-1746.2008.05391.x","article-title":"Detection of HBV core romoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B","volume":"23","author":"Kusumoto","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1172\/JCI116281","article-title":"Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis","volume":"91","author":"Ehata","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/gast.2003.50003","article-title":"A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation","volume":"124","author":"Liu","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.20331","article-title":"Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation","volume":"40","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.antiviral.2012.10.001","article-title":"The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy","volume":"96","author":"Chang","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.icb.7100009","article-title":"Immunopathogenesis of hepatitis B virus infection","volume":"85","author":"Chang","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0676.1994.tb00071.x","article-title":"Fluctuations in vlremla, amlnotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations","volume":"14","author":"Mels","year":"1994","journal-title":"Liver"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840070102","article-title":"Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis","volume":"7","author":"Liaw","year":"1987","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0676.1988.tb00998.x","article-title":"Changes of serum HBV DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis","volume":"8","author":"Liaw","year":"1988","journal-title":"Liver"},{"key":"ref_42","first-page":"948","article-title":"Immunohistochemical studies on intrahepatic lymphocyte infiltrates in chronic type B hepatitis, with spectal emphasis on the activation status of the lymphocytes","volume":"83","author":"Yang","year":"1988","journal-title":"Am. J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/370650a0","article-title":"Cytolybc T-cell cytotoxicty is medtated through perforin and Fas lytic pathways","volume":"370","author":"Lowin","year":"1994","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/00365529209011173","article-title":"Hepatitis B core antigen-specific interferon gamma production of peripheral blood mononuclear cells during acute exacerbation of chronic hepatitis B","volume":"27","author":"Takehara","year":"1992","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2249.1995.tb03720.x","article-title":"The expression of IL-2, IL-4 and interferon-gamma (IFN-\u03b3) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B","volume":"100","author":"Fukuda","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","article-title":"Interleukin-17-producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/jgh.12606","article-title":"Serum cytokine\/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications","volume":"29","author":"Wu","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2009.12.015","article-title":"A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B","volume":"52","author":"Tan","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-230X-12-109","article-title":"Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B","volume":"12","author":"Wenjin","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clim.2008.04.006","article-title":"Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients","volume":"128","author":"Chen","year":"2008","journal-title":"Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.humimm.2010.07.013","article-title":"Correlation of TLR1\u201310 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure","volume":"71","author":"Wang","year":"2010","journal-title":"Hum. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cld.2014.07.011","article-title":"Molecular adsorbent recirculating system and bioartificial devices for liver failure","volume":"18","author":"Catalina","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: The management of acute liver failure","volume":"41","author":"Polson","year":"2005","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCC.0b013e328344b3aa","article-title":"Acute-on-chronic liver failure: Extracorporeal liver assist devices","volume":"17","author":"Hassanein","year":"2011","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"HELIOS Study Group. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial","volume":"57","author":"Nevens","year":"2013","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2893.2002.00385.x","article-title":"The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice","volume":"9","author":"Chan","year":"2002","journal-title":"J. Viral. Hepat."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1746.2004.03534.x","article-title":"Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B","volume":"20","author":"Tsubota","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e65952","DOI":"10.1371\/journal.pone.0065952","article-title":"The efficacy and safety of Nucleos(t)ide analogues in patients with spontaneous acute exacerbation of chronic hepatitis B: A systematic review and meta-analysis","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_61","first-page":"261","article-title":"Short-term entecavir therapy of chronic severe hepatitis B","volume":"8","author":"Chen","year":"2009","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-011-0160-7","article-title":"Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"12","author":"Chen","year":"2012","journal-title":"Clin. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12072-012-9344-9","article-title":"Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: Establishment of a novel logistical regression model","volume":"6","author":"Ma","year":"2012","journal-title":"Hepatol. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)30776-8","article-title":"The efficacy and safety of entecavir in patients with chronic hepatitis B-associated liver failure: A meta-analysis","volume":"14","author":"Zhang","year":"2015","journal-title":"Ann. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1665-2681(19)30998-6","article-title":"The efficacy and safety of ucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: A meta-analysis","volume":"12","author":"Yu","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23346","article-title":"Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function","volume":"50","author":"Lange","year":"2009","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.dld.2011.06.013","article-title":"Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis","volume":"43","author":"Marzano","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jhep.2014.03.004","article-title":"The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B)","volume":"60","author":"Shouval","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10620-010-1257-7","article-title":"Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure","volume":"55","author":"Cui","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1499-3872(13)60025-9","article-title":"Short-term entecavir vs. lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure","volume":"12","author":"Lai","year":"2013","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3892\/etm.2012.850","article-title":"Entecavir and lamivudine therapy for severe acute chronic hepatitis B","volume":"5","author":"Liu","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3748\/wjg.v20.i16.4745","article-title":"Entecavir vs. lamivudine therapy for na\u00efve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"28","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jhep.2014.02.013","article-title":"Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation","volume":"60","author":"Chen","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2010.06.043","article-title":"Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B","volume":"54","author":"Wong","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/AAC.02400-13","article-title":"Early entecavir treatment for chronic hepatitis B with severe acute exacerbation","volume":"58","author":"Tsai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.3748\/wjg.v19.i39.6665","article-title":"Effects of entecavir and lamivudine for hepatitis, B decompensated cirrhosis: Meta-analysis","volume":"19","author":"Ye","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_78","first-page":"S333","article-title":"Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B","volume":"17","author":"Liaw","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/S1386-6532(05)80025-3","article-title":"The current management of HBV drug resistance","volume":"34","author":"Liaw","year":"2005","journal-title":"J. Clin. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/135965350801300407","article-title":"Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B","volume":"13","author":"Wong","year":"2008","journal-title":"Antivir. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: Update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver (2012). EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J. Hepatol., 57, 167\u2013185.","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00261-15","article-title":"Tenofovir vs. Entecavir in treatment of chronic hepatitis B virus with severe acute exacerbation","volume":"59","author":"Hung","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/368083","article-title":"Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B","volume":"36","author":"Lai","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine","volume":"27","author":"Allen","year":"1998","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/jhep.2001.22166","article-title":"Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region","volume":"33","author":"Stuyver","year":"2001","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-8278(02)00335-5","article-title":"Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: Emergence of YMDD motif mutant and risk of breakthrough hepatitis\u2014An open-cohort study","volume":"38","author":"Akuta","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jmv.20453","article-title":"High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations","volume":"77","author":"Zhang","year":"2005","journal-title":"J. Med. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/135965350501000612","article-title":"Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir","volume":"10","author":"Sheldon","year":"2005","journal-title":"Antivir. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"Fung","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3851\/IMP1552","article-title":"Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy","volume":"15","author":"Yeh","year":"2010","journal-title":"Antivir. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","article-title":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro","volume":"77","author":"Delaney","year":"2003","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/viro.2002.1448","article-title":"Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the \u201cfingers\u201d subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene","volume":"299","author":"Torresi","year":"2002","journal-title":"Virology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2006.08.013","article-title":"Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient","volume":"131","author":"Villet","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.gastro.2006.12.001","article-title":"Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance","volume":"132","author":"Hsu","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1053\/jhep.2000.7296","article-title":"Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy","volume":"31","author":"Yeh","year":"2000","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jac\/dkn014","article-title":"Hepatitis B virus escape mutants induced by antiviral therapy","volume":"61","author":"Sheldon","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/135965350801300313","article-title":"Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant","volume":"13","author":"Sloan","year":"2008","journal-title":"Antivir. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/gast.2002.31015","article-title":"Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation","volume":"122","author":"Bock","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.clinthera.2006.12.016","article-title":"Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: Evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors","volume":"28","author":"Dai","year":"2006","journal-title":"Clin. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.3748\/wjg.v18.i33.4604","article-title":"What MELD score mandates use of entecavir for ACLF-HBV BeAg-negative patients?","volume":"18","author":"Yan","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/17474124.2014.906899","article-title":"Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: An evidence-based review","volume":"8","author":"Wu","year":"2014","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_105","first-page":"2272","article-title":"Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure","volume":"125","author":"He","year":"2012","journal-title":"Chin. Med. J. Engl."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3851\/IMP2435","article-title":"Pretreatment viral DNA stratifies mortality risk in patients receiving antiviral therapy for severe acute exacerbation of chronic hepatitis B","volume":"18","author":"Hsu","year":"2013","journal-title":"Antivir. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/12\/26087\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:52:48Z","timestamp":1760215968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/12\/26087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":107,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["ijms161226087"],"URL":"https:\/\/doi.org\/10.3390\/ijms161226087","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]}}}